Since 2000, pharmaceuticals for common psychiatric conditions aged out of patent protection. After generic entry, supply increases as more sellers enter the market, leading to lower prices – about 80-85% less! Cheaper prescriptions and more treatment are the stated goal of policies to improve affordability. …Drug prices definitely fell during this period. For the SSRI sertraline, consumer cost per month dropped from ~35 dollars in […]
Incentives matter, the demand curve slopes downward, mental health edition
Incentives matter, the demand curve slopes downward, mental health edition
17 Oct 2024 Leave a comment
in applied price theory, economic history, health economics
Recent Comments